Search

everythinglearnresearchcommunity

for

Search:↓

In 2002, various drugs caused serious side effects, including vitamin B12 deficiency, heart issues, blindness, hypersexuality, allergic reactions, blood clotting problems, pupil dilation, capillary leak syndrome, muscle breakdown, hepatitis, skin reactions, and lupus.

Early detection and intensive treatment of diseases caused by Staphylococcus aureus toxins are crucial for reducing severe health effects.

A mother and son both had ulcerative colitis and alopecia, suggesting a genetic link in autoimmune disorders and successful treatment with cyclosporine.

Short scalp flaps are easier but not good for severe baldness; Juri flaps are complex but better for density and coverage.

The document concludes that various findings in rheumatology offer insights into disease severity, treatment responses, and potential risks in medication, with some limitations due to unspecified participant numbers.

The document reports findings on genetic research, including ethical concerns about genome editing, improved diagnosis of mitochondrial mutations, solving inherited eye diseases, confirming gene roles in epilepsy, linking a gene to aneurysms, and identifying genes associated with age-related macular degeneration.

Plasma protein binding significantly affects glucocorticosteroid concentration in blood, saliva, and hair.

Upadacitinib effectively treated severe atopic dermatitis, vitiligo, and alopecia areata in one patient.

Lupus treatment requires a combination of drugs and therapies, with research needed for new options.

No treatment reliably changes Alopecia Areata's course; reassurance and possibly a wig are recommended.

Antituberculous drugs improved symptoms in a woman with lupus and myositis.

Mycophenolate mofetil is effective for treating severe lupus nephritis in children.

Abrocitinib may effectively treat stubborn alopecia universalis.

A patient with a nerve disorder died from infection complications after developing insulin resistance from a treatment.

Rituximab improved her dermatomyositis better than usual treatments.

Hair loss may be a delayed side effect of Multisystem Inflammatory Syndrome in children after COVID-19.

Low-dose chemotherapy is safer, more effective, and cost-effective than surgery for treating bone lesions in children.

A mix of methotrexate, corticosteroids, and topical minoxidil effectively treated severe total body hair loss, but caused stretch marks and needs long-term monitoring.

Sumatriptan injections, high-flow oxygen, and verapamil effectively treat cluster headaches.

ABCD1 gene mutations cause adrenomyeloneuropathy, leading to symptoms like limb weakness and spasticity, with management focusing on rehabilitation and spasticity treatment.

Japanese patients with alopecia areata often have a higher BMI and consume more vitamin C, fruit, and retinol, which may affect their condition's development or severity.

Early treatment with corticosteroids and immunosuppressants is crucial for managing Vogt-Koyanagi-Harada disease.

Tofacitinib may cause nerve damage in the brain, so monitor for neurological symptoms.

Acne may signal underlying metabolic issues, and lifestyle changes can help manage both.

Beta-trace protein may help diagnose and predict treatment response in certain nerve disorders.

Men and women respond differently to drugs for COVID-19, high cholesterol, and diabetes, which suggests a need for personalized treatments.

Budesonide is not effective for maintaining remission in Crohn's disease beyond three months.

COVID-19 can cause long-term health issues in many body systems, and vaccination is important to prevent these effects.

Curcumin shows promise in reducing pain and inflammation, but more research is needed.

Oral feline interferon-omega improved symptoms in diabetic cats with gingivostomatitis.